CHICAGO — Immunocore reported Friday that in an early-stage study, 56% of melanoma patients who received its experimental drug achieved disease control — a measurement that …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
VANCOUVER, BC, Jan. 1, 2025 /PRNewswire/ – Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) (“Numinus” or the “Company“), a leader in mental health care specializing in innovative and evidence-based treatments, today
Nick Stepro, Chief Product and Technology Officer, Arcadia In healthcare, where the stakes are incredibly high, the speed at which we can share, process, and
In healthy brains, immune cells called microglia patrol for damage, clearing away debris and harmful proteins. But in the presence of the APOE4 protein-;the most